4Zapata LB, Whiteman MK, Tepper NK, et al. Intrauterine device use among women with uterine fibroids: a systematic review [J]. Contraception, 2010, 82(1): 41-55.
5Glass T, Baker T, Kauffman RP. Migration of an intrauterine contra- ceptive device during the course of pregnancy: A case report [J]. Journal of Minimally Invasive Gynecology, 2009,81-83.
6Naomi K, Lauren B, Jamieson D J, et al. Use of intrauterine devices in women with uterine anatomic abnormalities [J]. International Joumal of Gynecology, 2010, 109(1): 52-54.
7Smeets AJ, Nijenhuis RI, Boekkooi PF, et al. Is an Inla-auterine De- vice a Contraindication for Uterine Artery Embolization? A Study of 20 Patients [J]. Journal of Vascular and Interventional Radiology, 2010, 21 (2): 272-274.
8Mansour D. The benefits and risks of using a lcvonorgestrel-relcas- ing intrauterine system for contraception [J]. Contraception,2012, 85 (3): 224-234.
9Usama M, Dalia Y, Hassan M. Uterine artery blood flow in patients with copper intrauterine device-induced abnormal uterine bleeding [.l]. Middle East Fertility Society Journal, 2010, 15(3):168-173.
10Lete I, del Carme Cuesta M, Juan M, et al. Acceptability of the levo- norgestrel intrauterine system in the long-term treatment of heavy menstrual bleeding: how many women choose to use a second de- vice? [J]. European Journal of Obstetrics, 2011, 154(I): 67-70.
